CPCRX – Comstock Capital Value I Fund Stock Price | Morningstar

Skip to Content

NAV / 1-Day Return 4.03 / 0.00
Total Assets 6.0 Mil
Adj. Expense Ratio

—
Expense Ratio —
Distribution Fee Level Low
Share Class Type Institutional
Category Trading—Inverse Equity
Investment Style Small Growth
Min. Initial Investment 500,000
Status Closed
TTM Yield —
Turnover 265%

There is no Morningstar’s Analysis data available.

Portfolio Holdings CPCRX

More CPCRX Holdings

Current Portfolio Date Apr 30, 2023
Equity Holdings 54
Bond Holdings 0
Other Holdings 15
% Assets in Top 10 Holdings 34.7

Top 10 Holdings

% Portfolio Weight

Market Value USD

Sector

United States Treasury Bills 4.57996%

5.09

263,151

Government

Horizon Therapeutics PLC

4.95

255,668

Healthcare

United States Treasury Bills 5.0076%

4.59

237,375

Government

Oak Street Health Inc Ordinary Shares

4.53

233,820

Healthcare

United States Treasury Bills 4.58986%

3.97

204,929

Government

Activision Blizzard Inc

3.76

194,275

Communication Services

Maxar Technologies Inc

3.57

184,520

Technology

United States Treasury Bills 4.74326%

3.57

184,479

Government

Aerojet Rocketdyne Holdings Inc

3.55

183,332

Industrials

PNM Resources Inc

3.26

168,455

Utilities

Transparency is our policy. Learn how it impacts everything we do

Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams. And we have unwavering standards for how we keep that integrity intact, from our research and data to our policies on content and your personal data.

We’d like to share more about how we work and what drives our day-to-day business.

How we make money

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions. Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters.

How we use your personal data

How we use your information depends on the product and service that you use and your relationship with us. We may use it to:

Verify your identity, personalize the content you receive, or create and administer your account.
Provide specific products and services to you, such as portfolio management or data aggregation.
Develop and improve features of our offerings.
Gear advertisements and other marketing efforts towards your interests.

To learn more about how we handle and protect your data, visit our privacy center.

How we approach editorial content

Maintaining independence and editorial freedom is essential to our mission of empowering investor success. We provide a platform for our authors to report on investments fairly, accurately, and from the investor’s point of view. We also respect individual opinions––they represent the unvarnished thinking of our people and exacting analysis of our research processes. Our authors can publish views that we may or may not agree with, but they show their work, distinguish facts from opinions, and make sure their analysis is clear and in no way misleading or deceptive.

To further protect the integrity of our editorial content, we keep a strict separation between our sales teams and authors to remove any pressure or influence on our analyses and research.

Read our editorial policy to learn more about our process.